Riskpilot← Back to searchSign inGet full accessKrontec AB
ABActiveOrg 5567005037Rörsäng 104Manufacture of instruments and appliances for measuring, testing and navigation · NACE 2651Est. 20061 employees
Revenue 2025
SEK 414K
+27% vs 2024
EBITDA margin
25.3%
+52% vs 2024
Equity ratio
77.5%
Financial strength
Net profit 2025
SEK 95K
+699% vs 2024
| Revenue | SEK 414K | +27% |
| EBITDA | SEK 105K | +52% |
| Net profit | SEK 95K | +699% |
| Total assets | SEK 695K | +25% |
| Equity | SEK 539K | +21% |
| Employees | 1 | — |
Legal name
Krontec AB
Org number
5567005037
Legal form
Aktiebolag
NACE code
2651 · Manufacture of instruments and appliances for measuring, testing and navigation
Founded
22 mars 2006
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva konstruktion, tillverkning och försäljning av främst teknisk mätutrustning samt därmed förenlig verksamhet.
Address
Rörsäng 104
Email
conny@xenamedical.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 142 | 200 | 283 | 325 | 414 |
| Staff expenses | — | −6 | −0 | — | — |
| EBITDA | 80 | 75 | 92 | 69 | 105 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 80 | 75 | 92 | 69 | 105 |
| Net financials | — | — | 1 | 21 | 15 |
| Profit before tax | 80 | 0 | 93 | 15 | 120 |
| Tax | −17 | — | −19 | −3 | −25 |
| Net profit | 63 | 0 | 74 | 12 | 95 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 434 | 719 | 528 | 558 | 695 |
| Equity | 358 | 358 | 432 | 444 | 539 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 2 076 | 361 | 97 | 114 | 156 |
| Total debt | 2 076 | 361 | 97 | 114 | 156 |
EBITDA margin
25.3%
This company
15.8%
Market median
+60% vs market
20212025
Equity ratio
77.5%
This company
38.2%
Market median
+103% vs market
20212025
Return on equity
17.6%
This company
18.4%
Market median
+4% vs market
20212025
Net profit margin
23.0%
This company
8.1%
Market median
+184% vs market
20212025
Asset turnover
0.60×
This company
1.12×
Market median
-46% vs market
20212025
Debt / equity
0.29×
This company
0.62×
Market median
+53% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
MH Auditor Substitute | Auditor Substitute | 2020 – 2022 |
| Audit | 2020 – 2022 | |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2020 | |
| Board of Directors | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Xena Medical Aktiebolag
Krontec AB Board members of Krontec AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Maria Helena Fälton Björkman | Auditor Substitute | 0 companies |
| Kenneth Raine Christer Svensson | Audit | 0 companies |
| Jan Eric Hulin Erlingsson | Deputy Board Member | 0 companies |
| Jan-Erik Conny Erlingsson | Board of Directors | 0 companies |